Biolife Solutions (BLFS) Other Non-Current Assets (2010 - 2026)
Biolife Solutions (BLFS) reported Other Non-Current Assets of $3.0 million for Q1 2026, up 706.61% year-over-year from $378000.0 in Q1 2025, and little changed quarter-over-quarter from $3.0 million in Q4 2025.
Biolife Solutions (BLFS) Other Non-Current Assets (2010 - 2026) Analysis & Trends
Biolife Solutions (BLFS) has 17 years of Other Non-Current Assets data on file, last reported at $3.0 million in Q1 2026.
- Other Non-Current Assets for Q1 2026 came in at $3.0 million, up 706.61% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.0 million (up 706.61% YoY), and the FY2025 annual result was $3.0 million, up 717.69% from the prior year.
- Other Non-Current Assets held at $3.0 million in Q1 2026 per BLFS's latest filing, from $3.0 million in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $36.7 million in Q4 2023 and troughed at $31000.0 in Q4 2022.
- A 5-year average of $3.2 million and a median of $323000.0 in 2022 frame the typical range for Other Non-Current Assets.
- The sharpest annual moves came in 2023 and 2024: Other Non-Current Assets soared 118258.06% in 2023, then sank 98.98% in 2024.
- A 5-year view of Other Non-Current Assets shows it stood at $31000.0 in 2022, then soared by 118258.06% to $36.7 million in 2023, then slumped by 98.98% to $373000.0 in 2024, then soared by 717.69% to $3.0 million in 2025, then retreated by 0.03% to $3.0 million in 2026.
- Business Quant data shows BLFS's Other Non-Current Assets at $3.0 million in Q1 2026, $3.0 million in Q4 2025, and $2.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | - |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 2.43 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 446.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 210.73 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 81.30 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 848.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 672.80 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 39.83 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 692.00 Mn |
| 10 | Biolife Solutions | 1.27 Bn | 1.19 Bn | 17.50 Mn | 3.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.05 Mn |
| Dec 31, 2025 | 3.05 Mn |
| Sep 30, 2025 | 2.42 Mn |
| Jun 30, 2025 | 378,000.00 |
| Mar 31, 2025 | 378,000.00 |
| Dec 31, 2024 | 373,000.00 |
| Mar 31, 2024 | 245,000.00 |
| Dec 31, 2023 | 36.69 Mn |
| Sep 30, 2023 | 316,000.00 |
| Jun 30, 2023 | 316,000.00 |
| Mar 31, 2023 | 284,000.00 |
| Dec 31, 2022 | 31,000.00 |
| Sep 30, 2022 | 256,000.00 |
| Jun 30, 2022 | 323,000.00 |
| Mar 31, 2022 | 265,000.00 |
| Dec 31, 2021 | 325,000.00 |
| Sep 30, 2021 | 386,000.00 |
| Jun 30, 2021 | 452,000.00 |
| Mar 31, 2021 | 356,000.00 |
| Dec 31, 2020 | 230,000.00 |